← Leaderboards
Suthat Liangpunsakul
Indiana University Indianapolis
$8,638,123
Attributed
$15,897,343
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,897,343 · 14
VA$0 · 2
By mechanism
R01$7,060,751 · 5
U01$5,704,571 · 3
UH3$1,164,064 · 1
R21$836,835 · 2
K08$658,969 · 1
UH2$447,152 · 1
Top collaborators
- Shelly Chi-Loo Lu6 shared
- Timothy Ross Morgan6 shared
- Devanshi Seth6 shared
- John B Whitfield6 shared
- Bin Gao5 shared
- Wanzhu Tu5 shared
- Gianfranco D. Alpini4 shared
- Christopher Paul Day4 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Margaret S Stockdale$601,647
- Ann Carol Kimble-Hill$1,085,483
- Jing Su$1,724,005
- Sarah Elizabeth Wiehe$24,116,792
- Alan Benjamin McGuire$2,127,945
Others in their field
Top investigators on “Alcohol Consumption”
- Richard A Miech · Johns Hopkins University$46,450,970
- Adolf Pfefferbaum · Sri International$37,828,119
- Amy Caroline Justice · Philadelphia Va Medical Center$37,631,036
- Kathleen A Grant · Oregon Health & Science University$33,412,314
- Marisa Roberto · Scripps Research Institute, The$30,508,961
- Lloyd D Johnston · University Of Michigan At Ann Arbor$28,120,019
Research focus
Alcohol ConsumptionAlcoholsAlcoholic Liver DiseasesPathogenesisLiver DiseasesLeadComplexCellsResponseAlcoholic Liver CirrhosisLiverSerumPathway InteractionsHepaticUnited StatesGenesInflammatoryProblem DrinkerFibrosisLinkCirrhosisHepatocyteRisk FactorsFunctional Disorder
Grant awards (65)
FKBP5 in the pathogenesis of alcohol-associated liver disease$356,625
R01 · FY2025 · AA · contact PI
GAIPA: Graph artificial intelligence for precision identification of alcohol use disorder$222,762
R21 · FY2025 · AA
Alcohol-Induced End Organ Diseases Meetings$1
R13 · FY2025 · AA
Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use$0
I01 · FY2025 · VA · contact PI
FKBP5 in the pathogenesis of alcohol-associated liver disease$356,625
R01 · FY2024 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$273,786
U01 · FY2024 · AA · contact PI
GAIPA: Graph artificial intelligence for precision identification of alcohol use disorder$183,421
R21 · FY2024 · AA
Alcohol-Induced End Organ Diseases Meetings$25,000
R13 · FY2024 · AA
Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use$0
I01 · FY2024 · VA · contact PI
Mechanism of PDK4 and MAM axis in alcohol-associated liver disease$0
I01 · FY2024 · VA · contact PI
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis$536,418
R01 · FY2023 · AA
FKBP5 in the pathogenesis of alcohol-associated liver disease$356,625
R01 · FY2023 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$352,736
U01 · FY2023 · AA · contact PI
Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use$0
I01 · FY2023 · VA · contact PI
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis$537,781
R01 · FY2022 · AA
Novel animal models to study miRNA-mediated alcoholic liver disease$379,711
UH3 · FY2022 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$352,779
U01 · FY2022 · AA · contact PI
FKBP5 in the pathogenesis of alcohol-associated liver disease$350,307
R01 · FY2022 · AA · contact PI
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis$211,548
U01 · FY2022 · AA · contact PI
Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use$0
I01 · FY2022 · VA · contact PI
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis$540,508
R01 · FY2021 · AA
Novel animal models to study miRNA-mediated alcoholic liver disease$388,103
UH3 · FY2021 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$353,008
U01 · FY2021 · AA · contact PI
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis$211,548
U01 · FY2021 · AA · contact PI
Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use$0
I01 · FY2021 · VA · contact PI
Mechanistic-based biomarkers of abusive alcohol consumption$0
I01 · FY2021 · VA · contact PI
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis$554,365
R01 · FY2020 · AA
Novel animal models to study miRNA-mediated alcoholic liver disease$396,250
UH3 · FY2020 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$365,634
U01 · FY2020 · AA · contact PI
Novel biomarkers as a clinical tool for excessive alcohol use screening$355,348
R01 · FY2020 · AA · contact PI
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis$195,761
U01 · FY2020 · AA · contact PI
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis$194,079
U01 · FY2020 · AA · contact PI
Mechanistic-based biomarkers of abusive alcohol consumption$0
I01 · FY2020 · VA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$380,663
U01 · FY2019 · AA · contact PI
Novel biomarkers as a clinical tool for excessive alcohol use screening$358,892
R01 · FY2019 · AA · contact PI
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver disease$348,879
R01 · FY2019 · DK · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$336,491
R01 · FY2019 · AA
Novel animal models to study miRNA-mediated alcoholic liver disease$215,302
UH2 · FY2019 · AA · contact PI
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis$195,761
U01 · FY2019 · AA · contact PI
Mechanistic-based biomarkers of abusive alcohol consumption$0
I01 · FY2019 · VA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$373,523
U01 · FY2018 · AA
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver disease$348,986
R01 · FY2018 · DK · contact PI
Novel biomarkers as a clinical tool for excessive alcohol use screening$340,756
R01 · FY2018 · AA · contact PI
Novel animal models to study miRNA-mediated alcoholic liver disease$231,850
UH2 · FY2018 · AA · contact PI
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis$195,761
U01 · FY2018 · AA · contact PI
Mechanistic-based biomarkers of abusive alcohol consumption$0
I01 · FY2018 · VA · contact PI
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver disease$349,092
R01 · FY2017 · DK · contact PI
Novel biomarkers as a clinical tool for excessive alcohol use screening$344,914
R01 · FY2017 · AA · contact PI
Long noncoding RNAs in alcoholic liver disease$189,211
R21 · FY2017 · AA · contact PI
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver disease$345,956
R01 · FY2016 · DK · contact PI
Novel biomarkers as a clinical tool for excessive alcohol use screening$342,183
R01 · FY2016 · AA · contact PI
Long noncoding RNAs in alcoholic liver disease$241,441
R21 · FY2016 · AA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$458,729
U01 · FY2015 · AA
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol Consumption$0
I01 · FY2015 · VA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$518,642
U01 · FY2014 · AA
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol Consumption$0
I01 · FY2014 · VA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$518,431
U01 · FY2013 · AA
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol Consumption$0
I01 · FY2013 · VA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$552,182
U01 · FY2012 · AA
Effect of ethanol on Kupffer cell/hepatocyte interactions and lipid metabolism$134,131
K08 · FY2012 · AA · contact PI
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol Consumption$0
I01 · FY2012 · VA · contact PI
Effect of ethanol on Kupffer cell/hepatocyte interactions and lipid metabolism$134,158
K08 · FY2011 · AA · contact PI
Effect of ethanol on Kupffer cell/hepatocyte interactions and lipid metabolism$131,814
K08 · FY2010 · AA · contact PI
Effect of ethanol on Kupffer cell/hepatocyte interactions and lipid metabolism$129,538
K08 · FY2009 · AA · contact PI
Effect of ethanol on Kupffer cell/hepatocyte interactions and lipid metabolism$129,328
K08 · FY2008 · AA · contact PI